Patient Recruitment for Women's Health Clinical Trials: Understanding Patient Perspectives
Women's health conditions such as Polycystic Ovary Syndrome (PCOS), endometriosis, and uterine fibroids significantly impact women globally. With increasing awareness and demand for effective treatments, clinical trials in these fields are growing to address the unique needs of women. This growth reflects ongoing advancements in understanding and managing these conditions.
Clinical research plays a critical role in deepening our understanding of these conditions and developing targeted treatments. Women’s health trials often involve diverse patient profiles influenced by factors such as genetics, hormonal changes, lifestyle, and environmental exposures.
These studies aim to enhance therapeutic options, improve disease management, and ultimately enhance the quality of life for women dealing with PCOS, endometriosis, and uterine fibroids.
A typical patient with polycystic ovary syndrome (PCOS) is often a young woman between the ages of 15 and 30, though it can be diagnosed at any stage of reproductive age. PCOS is one of the most common hormonal disorders affecting women, with symptoms often beginning in adolescence. The condition is more prevalent in women with a higher body mass index (BMI), as obesity is a common risk factor, but it can also occur in those at a healthy weight.
Endometriosis affects women of reproductive age, typically between the ages of 25 and 40, though it can affect women of any age, including adolescents. The condition is more common in women with a family history of endometriosis or other autoimmune diseases. Caucasian and Asian women tend to have a higher prevalence, but it affects all ethnic groups.
Despite the availability of effective treatments and management options for various women's health conditions, barriers like stigma, limited awareness of clinical trial opportunities, and a preference for familiar healthcare providers can deter patients from considering clinical research as a viable pathway.
These challenges are particularly significant in women’s health, where misconceptions and limited understanding about the value of participating in clinical trials can prevent women from accessing potentially life-changing treatments and advancements in care.
Unlocking Access to participants Recruiting participants for clinical trials focused on women's health conditions, such as endometriosis, uterine fibroids, and polycystic ovary syndrome (PCOS), can be challenging. However, Direct-to-Patient Recruitment offers an effective strategy to engage a wide and diverse patient population.
These conditions are often researched online by individuals and caregivers seeking information on treatment options, symptom management, community support, and emerging therapies. This digital activity enables the use of advanced targeting and screening technologies to connect potential participants with clinical trial opportunities tailored to their specific health needs.
This approach not only raises awareness about available trials but also empowers women and their caregivers to explore personalized, research-driven solutions. By bridging the gap between innovative medical research and underserved populations, it ensures broader access to cutting-edge treatments and supports the advancement of women's health research.
Increased Enrollment
Months Saved
Randomization Contribution
AutoCruitment’s patient recruitment platform supports Sponsors, CRO Partners and Research Sites by decreasing time, risk and cost to bring new therapies to market.
